ESC 365 - Mavacamten reduces left ventricular mechanical dispersion in hypertrophic obstructive cardiomyopathy

Delegates Premium Access

Mavacamten reduces left ventricular mechanical dispersion in hypertrophic obstructive cardiomyopathy

Session: Imaging of the hypertrophied left ventricle

Topic: Myocardial Disease

Speaker: Doctor B. Ozbay (Pittsburgh, US)

Event: EuroEcho-Imaging 2024

Congress Presentation

Add to my library

About the speaker

Doctor Benay Ozbay

Upmc University Of Pittsburgh Medical Center, Pittsburgh (United States of America)

0 follower

4 more presentations in this session

Right atrial strain in Anderson-Fabry disease

Speaker: Doctor R. Lillo (Rome, IT)

Abnormal right ventricular strain predicts poor prognosis in transthyretin amyloidosis

Speaker: Doctor S. Istratoaie (Cluj Napoca, RO)

Differential diagnosis of hypertrophic cardiomyopathy, fabry cardiomyopathy and transthyretin cardiac amyloidosis: insights from right ventricular strain imaging echocardiography

Speaker: Doctor E. Mata (Creixomil, PT)

The cardiac myosin inhibitor mavacamten reduces even extreme left ventricular outflow gradient in obstructive hypertrophic cardiomyopathy already after one week of treatment

Speaker: Doctor V. Nagy (Szeged, HU)

Access the full session

Imaging of the hypertrophied left ventricle

Speakers: Doctor B. Ozbay, Doctor R. Lillo, Doctor S. Istratoaie, Doctor E. Mata, Doctor V. Nagy

About the event

EuroEcho-Imaging 2024

11 December - 13 December 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources